MARKET

ANIX

ANIX

Anixa Biosciences Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.520
-0.230
-6.13%
After Hours: 3.500 -0.02 -0.57% 16:51 10/14 EDT
OPEN
3.750
PREV CLOSE
3.750
HIGH
3.750
LOW
3.510
VOLUME
61.49K
TURNOVER
--
52 WEEK HIGH
6.86
52 WEEK LOW
3.250
MARKET CAP
71.13M
P/E (TTM)
-4.5507
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ANIX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ANIX News

  • Anixa Biosciences Names Cancer Vaccine Pioneer Dr. Ian H. Frazer to Scientific Advisory Board
  • PR Newswire.4d ago
  • Anixa Biosciences Announces University of Maryland School of Medicine to Join Cchek Prostate Cancer Study
  • PR Newswire.09/23 12:00
  • Should You Worry About Anixa Biosciences, Inc.'s (NASDAQ:ANIX) Cash Runway?
  • Simply Wall St..09/19 12:53
  • Anixa Biosciences Commences Collaboration with Potomac Urology Center on Cchek Prostate Cancer Study
  • PR Newswire.09/19 12:00

More

Industry

Biotechnology & Medical Research
+0.42%
Pharmaceuticals & Medical Research
+0.09%

Hot Stocks

Name
Price
%Change

About ANIX

Anixa Biosciences, Inc. is a biotechnology company. The Company is developing a cancer immunotherapy program, which leverages chimeric endocrine receptor t-cell (CER-T) technology, and is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers. The Cchek liquid biopsy technology is a series of non-invasive blood tests for early detection of solid tumors based on the body's immune response to a malignancy by detecting the presence, absence and quantity of certain immune cells that exist in and around a tumor and that enter the blood stream. This technology enables cancer detection in its earliest stages in efforts to treat patients when the disease is curable. The Company has developed techniques and protocols for measuring the subtle immunological changes that occur in the blood stream during tumor development. Through its protocols, the Company has detected the biomarkers in the peripheral blood of biopsy verified cancer patients.
More

Webull offers Anixa Biosciences Inc (ANIX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.